期刊文献+

高脂状态对大鼠动脉血管紧张素Ⅱ1型受体mRNA及一氧化氮的影响

Impact of hyperlipidemia on aortic angiotensin Ⅱ type 1 receptor mRNA expression and nitrogen monoxidum in rats
下载PDF
导出
摘要 目的观察高脂饮食对大鼠动脉血管紧张素Ⅱ1型受体(angiotensinⅡ1,AT1)mRNA表达、血清一氧化氮(nitrogen monoxidum,NO)水平的影响及降脂治疗的作用,探讨高脂饮食诱导内皮功能障碍的可能机制。方法将30只SD大鼠按电脑数字随机法分为3组,每组10只:正常对照组、高脂血症组和高脂血症治疗组。高脂血症组持续高脂喂养,高脂血症治疗组4周后在高脂喂养同时喂服辛伐他汀10mg/(kg·d),高脂血症组不予药物治疗。第20周末检测3组的血清脂蛋白浓度及AT1mRNA表达水平、血清AngⅡ和NO浓度。结果高脂血症组和高脂血症治疗组第4周末血清总胆固醇、三酰甘油、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇浓度均高于正常对照组,差异有统计学意义(P>0.05)。第20周末,高脂血症治疗组血清总胆固醇、三酰甘油、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇浓度低于高脂血症组差异有统计学意义(P>0.05)。3组第20周末收缩压比较,差异无统计学意义[(126±14)mm Hg vs.(127±13)mm Hg vs.(125±13)mm Hg,P>0.05;1mm Hg=0.133kPa]。方差分析显示,3组第20周末血清NO2-/NO3-浓度[(38.0±9.9)μmol/L vs.(29.6±7.2)μmol/L vs.(35.8±9.5)μmol/L,P<0.05]、主动脉组织AT1mRNA表达水平(0.66±0.05vs.0.75±0.08vs.0.70±0.06,P<0.05]差异有统计学意义;3组血清AngⅡ浓度比较差异无统计学意义(P>0.05)。相关分析结果显示,AT1mRNA表达水平与血清总胆固醇、三酰甘油浓度呈显著正相关(r=0.708,P<0.05;r=0.656,P<0.05)。结论高脂可能通过上调AT1受体表达和抑制NO活性而损伤血管,他汀类药物则可逆转这种状态,有利于阻止动脉硬化的发生发展。 Objectives To investigate the impact of hyperlipidemia on aortic angiotensin Ⅱ (Ang Ⅱ ) type 1 receptor (AT1)mRNA expression and nitrogen monoxidum(NO) in rats and study the effect of the statin therapy. Methods We divided 30 SD rats into 3 groups by randomized method: 10 rats in control group, 10 in hyperlipidemic group and 10 in simvastatin treated group. Hyperlipidemic rats were set on a consistent atherogenic diet in hyperlipidemic group, besides, hyperlipidemic models were set up on the 4-week athcrogenic diet and then followed by a 16-week treatment of simvastatin in the simvastatin treated group [simvastatin 10 mg/(kg ·d)]and without treatment in the hyperlipidemic group. The serum lipid level, expression of ATI mRNA of aorta and level of serum Ang Ⅱ and NO were measured in the end of the 20th week. Results After 4 weeks, serum concentrations of total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) of hyperlipidemic group and simvastatin treated group were higher than those of control group (P〈0.05). After 20 weeks, serum concentrations of TC ,TG, LDL-C, HDL-C of simvastatin treated group were significantly lower than those of hyperlipidemic group (P〈 0.05).After 20 weeks, analysis of variance indicated that systolic blood pressure among the 3 group had no significant difference [(126±14)mm Hgvs.(127±13)mm Hgvs.(125±13)mm Hg,P〉0.05; 1 mm Hg=0.133 kPa]; serum concentrations of NO2^-/NO3^- among the 3 groups had significant difference [ (38.0±9.9)μmol/L vs. (29.6±7.2)μmol/L vs. (35.8±9.5)μmol/L,P〈0.05] ;aortic AT1 mRNA expression among the 3 groups had significant difference (0.66±0.05 vs. 0.75±0.08 vs.0.70±0.06,P〈0.05] ; serum concentrations of Ang Ⅱ among the 3 group had no significant difference (P〉0.05). Correlation analysis indicated that aortie AT1 mRNA expression was postively correlated with serum concentration of TC and TG(r=0.708, P〈0.05 ; r=0.656,P〈0.05). Conclusions Hyperlipidernia could upregulate AT1 mRNA expression and inhibit the NO activity so that impaired the endothelial function which simvastatin could restore.
出处 《岭南心血管病杂志》 2010年第5期402-405,共4页 South China Journal of Cardiovascular Diseases
基金 广东省自然科学基金资助项目(项目编号:5300999) 广东省科技计划资助项目(项目编号:2009B080701033)
关键词 冠状动脉疾病 高脂血症 血管紧张素Ⅱ1型受体 一氧化氮 辛伐他汀 coronary artery disease hyperlipidemia angiotensin Ⅱ type 1 receptor nitric oxide simvastatin
  • 相关文献

参考文献9

  • 1THOMAS H E Jr,KANNEL W B,DAWBER T R,et al. Cholesterol-phospholipid ratio in the prediction of coronary heart disease.The Framingham study [ J ]. N Engl J Med, 1966,274 ( 13 ) : 701-705.
  • 2吴峻,孙明,周宏研,林锦潮,何兆初,区碧如.血管内皮生长因子与细胞黏附分子-1的表达及其对血管内皮功能的影响[J].中华老年医学杂志,2007,26(9):689-692. 被引量:8
  • 3吴峻,何兆初,易家骥,区碧如.辛伐他汀对大鼠心肌及血一氧化氮活性的影响[J].岭南心血管病杂志,2006,12(5):374-376. 被引量:1
  • 4JAWA A,NACHIMUTHU S,PENDERGRASS M,et al. Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy [J].J Clin Endocrinol Metab, 2006,91 ( 1 ) : 31-35.
  • 5KOGA J,EGASHIRA K,MATOBA T,et al. Essential role of angiotensin Ⅱ type 1 receptors in the host vascular wall, but not the bone marrow,in the pathogenesis of angiotensin Ⅱ - induced atherosclerosis [J ]. Hypertens Res, 2008,31 (9) : 1791 - 1800.
  • 6SU K H,TSAI J Y,KOU Y R,et al. Valsartan regulates the interaction of angiotensin Ⅱ type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signaling[J]. Cardiovasc Res, 2009,82 ( 3 ) : 468-475.
  • 7FERNANDEZ S F,HUANGM H,DAVIDSON B A,et al. Modulation of angiotensin Ⅱ responses in sympathetic neurons by cytosolic calcium [ J ]. Hypertension, 2003,41 ( 1 ) : 56-63.
  • 8JINX Q,FUKUDA N,SU J Z.Angiotensin Ⅱ type 2 receptor gene transfer downregulates angiotensin Ⅱ type 1 receptor in vascular s th muscle cells [ J ]. Hypertension, 2002, 39 (5): 1021-1027.
  • 9ICHIKI T,USUI M,KATO M,et al. Downregulation of angiotensin Ⅱ typerl receptor gent transcription by nitric oxide [J]. Hypertension, 1998,31 ( 1 Pt 2) : 342-348.

二级参考文献17

  • 1[1]THOMAS HE Jr,KANNEL WB,DAWBER TR,et al.Cholesterol-phospholipid ratio in the prediction of coronary heart disease,the Framingham study[J].N Engl J Med,1966,274(13):701-705.
  • 2[2]DZAU VJ,GIBBONS GH,MANN M,et al.Future horizons in cardiovascular molecular therapies[J].Am J Cardiol,1997,80(9A):331-391.
  • 3[5]VOGEL RA,CORRETTI MC,GELLMAN J.Cholesterol,cholesterol lowering,and endothelial function[J].Prog Cardiovasc Dis,1998,41 (2):117-136.
  • 4[6]HUANG A,SUN D,WU Z,et al.Estrogen elicits cytochrome P450-mediated flow-induced dilation of arterioles in NO deficiency:role of PI3K-Akt phosphorylation in genomic regulation[J].Circ Res,2004,94(2):245-252.
  • 5[7]YANG BC,PHILLIPS MI,MOHUCZY D,et al.Increased angiotensin Ⅱ type 1 receptor expression in hypercholesterolemic atherosclerosis in rabbits[J].Arterioscler Thromb Vasc Biol,1998,18(9):1433-1439.
  • 6[8]VILAHUR G,SEGALES E,CASANI L,et al.A novel anti-ischemic nitric oxide donor inhibits thrombosis without modifying haemodynamic parameters[J].Thromb Haemost,2004,91(5):1035-1043.
  • 7[9]BOULOUMIE A,SCHINI-KERTH VB,BUSSE R.Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells[J].Cardiovasc Res,1999,41 (3):773-780.
  • 8Ross R. Atherosclerosis is an in[lammatory disease. N Engl J Med, 1999, 340: 115-126.
  • 9Cybulsky MI, Lichtman AH, Hajra L, et al. Leukocyte adhesion molecules in atherogenesis. Clin Chim Acta, 1999, 286:207-218.
  • 10Krejsgaard T, Vetter-Kauczok CS, Woetmann A, et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia, 2006,20 : 1759-1766.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部